Alliance Clinical Research

Poway, California 92064

0 studies enrolling now · 9 studies all time

What they study most

Fibrosis, Liver, Hepatocellular Carcinoma, Hepatocellular Carcinoma Surveillance, NAFLD - Nonalcoholic Fatty Liver Disease, NASH, NASH - Nonalcoholic Steatohepatitis, Non Alcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Refractory Chronic Gout, Ulcerative Colitis

Studies at this site

• Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis — Completed
• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
• A Phase 2b Study of Icosabutate in Fatty Liver Disease — Completed
• A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients — Completed
• Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis — Stopped early
• A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma — Completed
• Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic Gout — Completed